| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-23 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.45 | 2e-17 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.4 | 7e-16 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |